Axons matter: The promise of treating neurodegenerative disorders by targeting SARM-1 mediated axonal degeneration.
…clinical biomarker will allow the development of a new class of therapeutics to treat axonopathies. Attempts to develop neuroprotective treatments for neurodegenerative disorders have not yet been clinically successful. Axonal…
read more